EURO-NMD has renewed its agreement with EMQN for another year and will once again cover the registration fees for laboratories affiliated with EURO-NMD Healthcare Providers participating in the 2027 Neuromuscular Disorders External Quality Assessment (EQA) Scheme.
Please use this form to express your interest in participating in the 2027 Neuromuscular Disorders EQA Scheme. EURO-NMD will cover the registration fees for up to 30 laboratories affiliated with EURO-NMD Healthcare Providers. Selection may be required if the number of expressions of interest exceeds the available funded places.
Participating laboratories will be able to register for one of the following options:
DMD/BMD Targeted Testing only
Neuromuscular Disease (NMD) Gene Panel Testing only
Neuromuscular Disease (NMD) Gene Panel Testing + DMD/BMD Targeted Testing